BMC Cancer

Table 1 The association between prevalent genotypes of human papilloma virus persistent positivity and cervical lesions

From: The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China

HPV persistent infection
Pathological stage	No. 15257	HPV +	χ ²	P	Multiple HPV(+)	χ ²	P	HPV 16+	χ ²	P	HPV 58+	χ ²	P	HPV 18+	χ ²	P	HPV 52+	χ ²	P	HPV 33+	χ ²	P
Stage 1
normal	10477	262	519.846	0.0001	98	404.940	0.0001	43	139.334	0.0001	59	494.956	0.0001	83	45.796	0.0001	55	59.537	0.0001	47	94.149	0.0001
CINI	2068	283			162			62			155			51			45			52
Stage 2
CINI	2068	283	2054.183	0.0001	162	107.486	0.0001	62	180.252	0.0001	155	0.444	0.522	51	5.929	0.016	45	4.881	0.031	52	3.019	0.094
CINII/III	1604	1426			311			247			111			62			54			56
Stage 3
CINII/III	1604	1426	0.53	0.5	311	1.245	0.271	247	0.046	0.829	111	0.321	0.571	62	6.374	0.013	54	1.999	0.157	56	0.677	0.378
Cervical cancer	1108	975			196			174			83			66			49			42

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com